View in EDS HTML Full Text PDF Full Text

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.

Saved in:
Bibliographic Details
Title: Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.
Authors: Foster L; Division of Hematology Oncology, University of Virginia, Charlottesville, VA, USA. LF5V@uvahealth.org., Anderson LD Jr; Myeloma, Waldenstrom's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Chung A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Chaulagain CP; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Weston, FL, USA., Pettijohn E; Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI, USA., Cowan AJ; Division of Medical Oncology, Fred Hutch Cancer Center/University of Washington, Seattle, WA, USA., Costello C; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Larson S; Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Sborov DW; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Silbermann R; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Voorhees P; Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, USA., Krevvata M; Johnson & Johnson, Spring House, PA, USA., Pei H; Johnson & Johnson, Titusville, NJ, USA., Patel S; Johnson & Johnson, Horsham, PA, USA., Khare V; Johnson & Johnson, Horsham, PA, USA., Cortoos A; Johnson & Johnson, Horsham, PA, USA., Carson R; Johnson & Johnson, Spring House, PA, USA., Lin TS; Johnson & Johnson, Horsham, PA, USA., Badros A; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Source: Blood cancer journal [Blood Cancer J] 2025 Oct 06; Vol. 15 (1), pp. 154. Date of Electronic Publication: 2025 Oct 06.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41053004
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Foster+L%22">Foster L</searchLink>; Division of Hematology Oncology, University of Virginia, Charlottesville, VA, USA. LF5V@uvahealth.org.<br /><searchLink fieldCode="AU" term="%22Anderson+LD+Jr%22">Anderson LD Jr</searchLink>; Myeloma, Waldenstrom's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chung+A%22">Chung A</searchLink>; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chaulagain+CP%22">Chaulagain CP</searchLink>; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Weston, FL, USA.<br /><searchLink fieldCode="AU" term="%22Pettijohn+E%22">Pettijohn E</searchLink>; Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Cowan+AJ%22">Cowan AJ</searchLink>; Division of Medical Oncology, Fred Hutch Cancer Center/University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Costello+C%22">Costello C</searchLink>; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Larson+S%22">Larson S</searchLink>; Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sborov+DW%22">Sborov DW</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Shain+KH%22">Shain KH</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Silbermann+R%22">Silbermann R</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Voorhees+P%22">Voorhees P</searchLink>; Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Krevvata+M%22">Krevvata M</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pei+H%22">Pei H</searchLink>; Johnson & Johnson, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Khare+V%22">Khare V</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cortoos+A%22">Cortoos A</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Carson+R%22">Carson R</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+TS%22">Lin TS</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Badros+A%22">Badros A</searchLink>; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Oct 06; Vol. 15 (1), pp. 154. <i>Date of Electronic Publication: </i>2025 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41053004
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-025-01355-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 154
    Titles:
      – TitleFull: Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Foster L
      – PersonEntity:
          Name:
            NameFull: Anderson LD Jr
      – PersonEntity:
          Name:
            NameFull: Chung A
      – PersonEntity:
          Name:
            NameFull: Chaulagain CP
      – PersonEntity:
          Name:
            NameFull: Pettijohn E
      – PersonEntity:
          Name:
            NameFull: Cowan AJ
      – PersonEntity:
          Name:
            NameFull: Costello C
      – PersonEntity:
          Name:
            NameFull: Larson S
      – PersonEntity:
          Name:
            NameFull: Sborov DW
      – PersonEntity:
          Name:
            NameFull: Shain KH
      – PersonEntity:
          Name:
            NameFull: Silbermann R
      – PersonEntity:
          Name:
            NameFull: Voorhees P
      – PersonEntity:
          Name:
            NameFull: Krevvata M
      – PersonEntity:
          Name:
            NameFull: Pei H
      – PersonEntity:
          Name:
            NameFull: Patel S
      – PersonEntity:
          Name:
            NameFull: Khare V
      – PersonEntity:
          Name:
            NameFull: Cortoos A
      – PersonEntity:
          Name:
            NameFull: Carson R
      – PersonEntity:
          Name:
            NameFull: Lin TS
      – PersonEntity:
          Name:
            NameFull: Badros A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 10
              Text: 2025 Oct 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1